The site will be unavailable in 28 minutes for scheduled maintenance.

$12.35 -0.43 (-3.33%)
2/10/2012 4:00 PM

VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Featured Broker Partners


Advertisement